accountJudith Graham's recent column on comparative effectiveness research (CER) ("Testing treatments. U.S. launching $1.1 billion study of which medical therapies work," Chicagoland, April 24) misses the most important component of CER--patients.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Patient-centered CER
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account